Market Place
Sourcing Support
All News #Library
Glaxosmithkline’s Lynavoy Receives Approval in US
17 Mar 2026 //
FDA
Glaxosmithkline’s Biologics Exdensur Receives Approval in US
16 Dec 2025 //
FDA
Glaxosmithkline’s Biologics Blenrep Receives Approval in US
23 Oct 2025 //
FDA
GSK`s Blenrep Receives Approval in Europe
23 Jul 2025 //
EMA
GlaxoSmithKline`s Blenrep Receives Approval in Canada
17 Jul 2025 //
HEALTH CANADA
GSK`s Biologics Benlysta Receives Suppl Approval in US
20 Jun 2025 //
FDA
GSK`s Biologics Nucala Receives Suppl Approval in US
22 May 2025 //
FDA
GSK`s Benlysta (belimumab) Receives Suppl Approval in the U.S
16 May 2024 //
FDA
GSK`s Biologic Benlysta (belimumab) Receives Approval in the U.S.
09 Feb 2024 //
FDA
GSK`s Biologic Jemperli (dostarlimab) Receives Approval in the U.S.
31 Jul 2023 //
FDA
GlaxoSmithKline`s Arexvy Vaccine Receives Approval in Europe
22 Jun 2023 //
EMA
GSK`s Biologic Nucala ( Mepolizumab) Receives Approval in the U.S.
08 Mar 2023 //
FDA
GSK`s Benlysta (Belimumab) Receives BLA Approval in the U.S.
26 Jul 2022 //
FDA
GlaxoSmithKline`s Dostarlimab Receives Supplemental Approval in U.S.
28 Apr 2022 //
FDA
GlaxoSmithKline`s Generic Nucala (Mepolizumab) Receives Approval in the U.S.
22 Jan 2022 //
FDA
GlaxoSmithKline`s Xevudy (Sotrovimab) Receives Approval in Europe
17 Dec 2021 //
EMA
Bristol Myers`s Biologic Orencia (Abatacept) Receives Approval in the U.S.
14 Dec 2021 //
FDA
GlaxoSmithKline`s Generic Blenrep Receives Approval in the U.S.
07 Dec 2021 //
FDA
GSK`s Biological Dostarlimab-Gxly Receives Approval In the US
18 Aug 2021 //
FDA
Glaxosmithkline Biological Mepolizumab Receives Approval in US
29 Jul 2021 //
FDA
Glaxosmithkline`s Biological Dostarlimab-Gxly Receives Approval In US
22 Apr 2021 //
FDA
Glaxosmithkline LLC`s Biological Mepolizumab Receives Approval In US
28 Sep 2020 //
FDA
Glaxosmithkline`s Biological Mepolizumab Receives Approval In US
25 Sep 2020 //
FDA
GlaxoSmithKline`s Blenrep (Belantamab Mafodotin) Receives Approval In Europe
17 Sep 2020 //
EMA
GlaxoSmithKline`s BENLYSTA (Belimumab) Receives Supplemental Approval in U.S
22 Jan 2020 //
FDA
Glaxosmithkline`s BENLYSTA (Belimumab) Receives Supplemental Approval In U.S
18 Jan 2020 //
FDA
Glaxosmithkline’s Benlysta (Belimumab) Receives Supplemental Approval In US
17 Sep 2019 //
FDA
Glaxosmithkline Nucala (Mepolizumab) Receives Supplemental Approval US
14 Sep 2019 //
FDA
GlaxoSmithKline`s Nucala Receives Approval In US
06 Jun 2019 //
FDA
Glaxosmithkline’s Benlysta (Belimumab) Receives Supplemental Approval In US
27 Jun 2018 //
FDA
Glaxosmithkline’s Nucala (Mepolizumab) Receives Supplemental Approval In US
18 Dec 2017 //
FDA
Glaxosmithkline’s Tanzeum (Albiglutide) Receives Supplemental Approval In US
03 Aug 2017 //
FDA
Glaxosmithkline’s Belimumab Receives Supplemental Approval In US
21 Jul 2017 //
FDA
Glaxosmithkline`s Supplement Nucala (Mepolizumab) Receives Approval In US
16 Feb 2017 //
FDA
GSK`s Nucala (Mepolizumab) approved in US for Asthma
04 Nov 2015 //
FDA
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.